Aptose Biosciences Completes Acquisition by Hanmi Pharmaceutical

Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS and OTC: APTOF), a clinical-stage precision oncology company develo...

July 02, 2026 | Thursday | News
Kimball Electronics Acquires Helvoet to Expand Global Medical CDMO Platform

Helvoet is an advanced medical CDMO specializing in highly automated micro-molding and precision injection molding for microfluidics, diagnostics, an...

July 02, 2026 | Thursday | News
Xellar Biosystems Raises $50 Million to Advance AI-Powered 3D Bio Intelligence Platform

Financing will accelerate the development of human-relevant biological data infrastructure, virtual cell technologies, and next-generation drug discovery...

July 01, 2026 | Wednesday | News
Innovent and Lilly Expand China Oncology Alliance with Verzenios Commercialization Agreement

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality...

July 01, 2026 | Wednesday | News
Evotec Launches J.TRAIN to Bring Continuous Biologics Manufacturing Directly to Partner Facilities

Expands Just – Evotec Biologics partner-enablement and technology licensing model for proprietary continuous manufacturing pl...

July 01, 2026 | Wednesday | News
LENZ Therapeutics Partners with Arrotex to Commercialize VIZZ in Australia and New Zealand

LENZ Therapeutics, Inc. (Nasdaq: LENZ) and Arrotex Pharmaceuticals Pty Ltd. (“Arrotex”) announced an exclusive license and commercialization ...

June 26, 2026 | Friday | News
Engineering Growth Beyond Capacity: How Integrated CDMO Expansion Is Reshaping Biologics Development

As the biologics landscape grows increasingly complex, CDMOs are under pressure to deliver more than additional manufacturing capacity. Emerging biotechs...

June 22, 2026 | Monday | News
Scaling Excellence: Samsung Biologics’ Vision for the Next Era of Biomanufacturing

  As the biopharmaceutical industry enters a new phase of growth, manufacturers are under increasing pressure to deliver greater capacity, accelerate...

June 23, 2026 | Tuesday | Expert Opinion
The Future of Biologics Demands More Than Capacity—It Demands True Partnership

    During BIO 2026, taking place June 22–25 at the San Diego Convention Center, BioPharma Boardroom spoke with Francis...

June 23, 2026 | Tuesday | Interaction
Redefining Biologics Partnerships Through Shared Risk and Scientific Collaboration

The biologics development landscape is becoming increasingly complex, requiring partners that offer more than manufacturing capacity alone. As biotech comp...

June 22, 2026 | Monday | Expert Opinion
Transforming Contamination Control from Compliance Requirement to Strategic Advantage

Contamination control is no longer viewed solely through the lens of compliance. Across today's biopharmaceutical manufacturing landscape, it has become a ...

June 23, 2026 | Tuesday | Interaction
Jazz Pharmaceuticals and AbCellera Partner to Develop Next-Generation T-Cell Engagers for Solid Tumors

The collaboration includes $56 million in upfront payments to AbCellera and up to $792 million in potential option fees and milestone payments for any pr...

June 19, 2026 | Friday | News
VIVEbiotech Reaches Milestone with 15th In Vivo Lentiviral Vector Program, Reinforcing Leadership in Gene Therapy Manufacturing

VIVEbiotech, a leading lentiviral vector Contract Development and Manufacturing Organization (CDMO),  underscored its industry leadership in the dev...

June 17, 2026 | Wednesday | News
Quintara Biosciences Relocates Boston-Area Laboratory to Watertown to Expand Sequencing Capacity

As a strategic step to better support growing demand and strengthen future service capacity, Quintara Biosciences announced that its Boston area laboratory...

June 15, 2026 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close